CV5 Capital and Enzyme form a strategic partnership to launch institutional-grade tokenized fund solutions
Foresight News reported that CV5 Capital has announced a strategic partnership with global tokenized financial infrastructure provider Enzyme, which will serve as the foundational technology stack for its tokenized fund issuance and management. CV5 Capital plans to leverage Enzyme Onyx to build, launch, and manage a new generation of investment products, supporting investment strategies across a variety of asset classes including cryptocurrencies, securities, commodities, and US Treasuries.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - McCormick's third-quarter sales exceed expectations, stock price rises
Cardinal Health extends CVS Health pharmaceutical distribution agreement through June 2032
The 10-year US Treasury yield hits its highest level since 2002! Oil prices return to $100, triggering a global bond sell-off, and the 30-year UK government bond rate breaks 6% for the first time
The yield on US benchmark Treasury bonds has reached its highest level since 2002 as bonds face heavy sell-off.
Markets reduce bets on European Central Bank rate hikes
Crypto prices
More
